NCT03331926已完成不适用
Collagenase Clostridium Histolytic is a Common Treatment of MCP and PIP Joint Contractures in Dupuytren Disease. A 1 to 4 Year Followup Study of 198 Joints
Jeppe Lange0 个研究点目标入组 199 人开始时间: 2017年1月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 199
- 主要终点
- Change in extension deficit from baseline to FU in MCP and PIP joints after treatment
研究概览
简要总结
To evaluate the effect of collagenase clostridium histolyticum treatment at the Department of Orthopaedic surgery at Horsens Regional Hospital after minimum one-year follow-up (FU).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •dupuytrens disease
- •xiapex treatment
排除标准
- •demens/other psychiatric diseases
结局指标
主要结局
Change in extension deficit from baseline to FU in MCP and PIP joints after treatment
时间窗: Minimum one year after treatment
次要结局
未报告次要终点
研究者
Jeppe Lange
Research secretary
Horsens Hospital
相似试验
进行中（未招募）
4 期
Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie'sPeyronie's DiseaseNCT04786106Charitable Union for the Research and Education of Peyronie's Disease40
已完成
2 期
Clostridium Histolyticum Collagenase Injection for Urethral DiseaseUrethral StrictureNCT02948842University of South Florida5
进行中（未招募）
4 期
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's DiseasePeyronie DiseaseSexual Dysfunctions, PsychologicalGenital Diseases, MaleNCT05777031University of Miami12
已完成
4 期
Efficacy of a Novel CCH Protocol for PD Among Prior Non-respondersPeyronie's DiseaseNCT05108558Charitable Union for the Research and Education of Peyronie's Disease40
进行中（未招募）
1 期
ocal injection of collagenase for difficult-to-treat scar strictures of the gastrointestinal tract.EUCTR2018-003637-14-BEGhent University Hospital10